{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-017825","form_type":"8-K","ticker":"PULM","cik":"0001574235","company_name":"Pulmatrix, Inc.","filed_at":"2021-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.633971+00:00","generated_at":"2026-06-30T02:11:56.401666+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Pulmatrix board member Mark Iwicki resigns; Anand Varadan appointed","bullets":["Mark Iwicki resigned from board on July 23, 2021, with no disagreement over operations or policies.","Anand Varadan appointed to board as Class III director effective July 26, 2021.","Varadan brings commercialization expertise as CCO of Chiasma and former CCO of Karyopharm.","Appointment aligns with Pulmatrix's expansion into non-respiratory indications using iSPERSE technology."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-017825","json":"https://secwatch.observer/filing/0001493152-21-017825.json","markdown":"https://secwatch.observer/filing/0001493152-21-017825.md","text":"https://secwatch.observer/filing/0001493152-21-017825.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574235/000149315221017825/0001493152-21-017825-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574235/000149315221017825/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T02:11:56.401666+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"271685e4ba","claim":"Anand Varadan was appointed as Director at Pulmatrix, Inc..","evidence_excerpt":"On July 23, 2021, Anand Varadan was appointed to the board of directors of the Company, effective as of July 26, 2021, to serve as a Class III director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1574235/000149315221017825/0001493152-21-017825-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"70abbb5b10","claim":"Mark Iwicki resigned as Director at Pulmatrix, Inc..","evidence_excerpt":"On July 23, 2021, Mark Iwicki resigned from the board of directors of Pulmatrix, Inc. (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1574235/000149315221017825/0001493152-21-017825-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}